#GoldenCross $ANAB at 25.73 R53 HiLo 53% T1Y 20 hold fwdPE -9.1 DIV N/A #AnaptysBio #stocks #trading #finance #market

2020-10-24
19 Views

Golden Cross detected for ANAB (AnaptysBio, Inc.) at the close price of 25.73. Trading at a 53 % level between the 52week High (39.48) and 52week Low (10.00). The average analyst 1-year target price is 20.0 with an average hold and a score of 0.0.

Golden Cross
53 %
ANAB
25.73
AnaptysBio, Inc.
HiLo
53.4 %
Support
16.75
Resistance
25.92
50DMA
17.50
200DMA
17.48
52week high
39.48
52week low
10.00
10DMA
22.93
20DMA
19.31
100 Mean
18.93
Volume
167023
AvgDayVol
276335
MarketCap
725032768
EBITDA
-88339000
Revenue
18000000
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance
Bear, Global Indicators
7 views
Bear, Global Indicators
7 views

HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

[Bearish] HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
7 views
Global Indicators,
7 views

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance
Global Indicators,
9 views
Global Indicators,
9 views

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.